Gene · 5602
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alterations in Both Caliber and Myelination of Callosal Axons Elicited by Ubiquitous Genetic Ablation of c-Jun Amino-Terminal Kinase 3 (JNK3). | J Neurochem | 2026 | 41567033 | PubTator, text mining | PubMed |
| SUMOylation of SND1 drives mature miRNA degradation and tumor progression. | Cancer Lett | 2026 | 41534786 | PubTator, text mining | PubMed |
| JNK3 regulates β cell responses to incretins in human islets and mouse models. | J Clin Invest | 2026 | 41480766 | PubTator, text mining | PubMed |
| Unlocking C-N Bond Formation via a Two-Photon ETU-FRET Relay with Near-Infrared Light. | Org Lett | 2026 | 41474793 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase 10 suppresses non-small cell lung cancer metastasis through phosphorylation-dependent ubiquitination of keratin 16. | Int J Biol Macromol | 2026 | 41435962 | PubTator, text mining | PubMed |
| Photopharmacology in Action: Conformational Landscape of a Photoswitchable Covalent Kinase Inhibitor. | J Phys Chem B | 2026 | 41403182 | PubTator, text mining | PubMed |
| Evidence-based validation of cardiovascular benefits from novel MRAs in type 2 diabetes: A meta-analysis of over 30,000 patients. | J Diabetes Complications | 2026 | 41317458 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of new triazolopyridazine-based derivatives as cyclin dependent kinase-4 inhibitors with apoptosis-inducing and tumor-suppressive effects. | Bioorg Med Chem | 2026 | 41092670 | PubTator, text mining | PubMed |
| Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer's Disease. | CNS Neurol Disord Drug Targets | 2026 | 40849746 | PubTator, text mining | PubMed |
| Identification of Pharmacophore Responsible for the JNK3 Enzyme Inhibition using KPLS-based QSAR Analysis. | Cent Nerv Syst Agents Med Chem | 2026 | 40033595 | PubTator, text mining | PubMed |
| CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. | Front Immunol | 2025 | 41472741 | PubTator, text mining | PubMed |
| MAPK Pathway Activation Patterns in the Synovium Reveal ERK1/2 and EGFR as Key Players in Osteoarthritis. | Biomedicines | 2025 | 41463004 | PubTator, text mining | PubMed |
| Explaining Isoform Selectivity of c-Jun N-Terminal Kinase 3 (JNK3) Inhibitors through Its Development and Structural Insights. | J Med Chem | 2025 | 41384353 | PubTator, text mining | PubMed |
| JNK3 quantification in plasma: a novel biomarker for neuronal damage in Parkinson's disease. | NPJ Parkinsons Dis | 2025 | 41372194 | PubTator, text mining | PubMed |
| A bioinformatic survey of RNA isoform diversity and expression across 9 GTEx tissues using long-read sequencing data. | BMC Genomics | 2025 | 41345545 | PubTator, text mining | PubMed |
| Pathway-guided architectures for interpretable AI in biological research. | Comput Struct Biotechnol J | 2025 | 41282420 | PubTator, text mining | PubMed |
| Review Article: Efficacy and Safety of JNK Inhibitors in Cancer Therapy. | Crit Rev Oncog | 2025 | 41275483 | PubTator, text mining | PubMed |
| REINFORCE-ING Chemical Language Models for Drug Discovery. | J Chem Inf Model | 2025 | 41241844 | PubTator, text mining | PubMed |
| Role of JNK3 signaling in acute ischemic stroke cerebroprotection: A systematic review. | Biomed Pharmacother | 2025 | 41237460 | PubTator, text mining | PubMed |
| Transcriptome sequencing reveals key role of ceRNA in regulating inflammation response after intracerebral hemorrhage. | Brain Res | 2025 | 41161665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5602/papers?page=3